movement disorders (cohen) Flashcards
PARKINSON’S DISEASE
Probably occurred for centuries, but first described in 1817 by James Parkinson
Increased incidence due to industrialization, large-scale agriculture?
Parkinson called it “the shaking palsy”
Tremulousness, weakness, bent or stooped posture, festinating gait, but “senses…not injured”
But we now know there is no palsy (weakness) in Parkinson’s Disease, and many patients do have dementia eventually
Parkinson’s Disease:Four cardinal features
- Resting tremor, usually beginning in one hand
- Bradykinesia, a slowness of movement, in initiating and executing movements, even in spontaneous facial expressions (stare)
- Dysequilibrium, or instability of gait and posture, leading to a higher risk of falls
- Rigidity, especially later in the course of the illness
Occasionally the diagnosis is made of PD with “only” resting tremor, but ideally patients should have at least three of these four signs
Definitions of Tremor
Tremor is a fairly regular, oscillatory, to-and-fro movement carried out by irregularly synchronous contractions of antagonistic muscles
It is rhythmic and biphasic, and limited in pattern over time, if not amplitude
Other movement disorders can vary minute-by-minute-, such as chorea, myoclonus, athetosis, and dystonic movements
Physiologic tremor is a normal tremor that occurs, especially with complex movements, mostly of the hands and fingers, but minimal disability to people
1. Exacerbated by fatigue , stress, drugs, and age
2. Faster frequency than pathological tremors
Tremor as a disease
Pathologic tremor disturbs normal functioning
Noticed by patients especially when it first appears, or worsens
Often regarded by patients and their families as a sign of nervousness or related to diet, especially caffeine or alcohol
Embarrassing to most patients, who often try to mask its appearance, or avoid friends or some public events
Occasionally hysterical: no regular rhythm, often just one arm or one leg, or will move if one limb is held
Resting Tremor in Parkinson’s
Perhaps the most common presentation of Parkinson’s, but about half of patients notice other symptoms first
Nearly always an ASYMMETRIC tremor of the hands, less commonly the legs
Considered a “resting tremor,” and may disappear for a moment with change in position of the hand
Usually 4-7 hertz in frequency
May spread less often to the lips and jaws but not the entire head
Occasionally the only feature of Parkinson’s
Present in 75 – 80% of patients eventually
Bradykinesia in Parkinson’s
Slowness of movement, almost becoming no movement
Patients may look like statues, especially when sitting; no fidgeting or easy adjustment of position; staring, almost a “reptilian” or “masked” look
Decreased rate of blinking; 5 – 10 instead of 15 – 20 /minute
Hard to swallow, so patients drool
Occasionally under duress, patients may walk or speak briefly with greater speed: kinesis paradoxica
Dysequilibrium in Parkinson’s
Hard to become steady on their feet
Often fall backwards, retropulsion, when starting to walk
Try to catch-up with themselves, so they walk faster and faster, or festination of gait
Can’t correct themselves while walking, so increased falls
Balance worsened by lack of arm swinging
One of the most dangerous signs, and least responsive to medication and surgery
Rigidity in Parkinson’s
Usually a later sign, but very debilitating
Perhaps the source of pain in many patients, along with cramps, especially in the shoulders
Seen by the physician in the form of cogwheeling, or ratcheting with passive movements of the patient’s arms or even legs
Especially problematic when a medication wears-off, or patients suddenly freeze in one position
Other early symptoms and signs of parkinson’s
Sleep disorders, such as insomnia or REM Behavior Disorder
Loss of sense of smell
Autonomic problems, such as impotence, incontinence, hypotension
Cramps, pains especially in the back and shoulders
Depression, loss of usually activities, sometimes an early dementia
Smaller, incomprehensible handwriting
Loss of power of voice, with monotonous and hurried speech
Pathology of Parkinson’s
Loss of cells (> 70%) in the substantia nigra, or “black body” in the midbrain, which projects dopamine releasing axons to the striatum of the cerebral hemispheres
Easily seen with an autopsy, but not quite yet with MRIs
In the striatum (caudate and putamen) there is a significant loss of dopaminergic transmission
Loss of other cells in brainstem, thalamus, cerebral hemispheres and autonomic ganglia
Lewy bodies
Eosinophilic structures in the cytoplasm of neurons, especially in the substantia nigra, but in multiple other locations in the brains of Parkinson’s patients
May be seen in the absence of Parkinson’s disease, including Lewy Body Disorder, or apparent Alzheimer’s Disease
Contain increased amounts of alpha-synuclein, as is true of neurons in patient with Lewy Body Disorder
Synuclein is a protein which helps facilitate the movement of synaptic vesicles to the end of the axon; why does the amount of synuclein increase so much in Parkinson’s Disease?
Genetics of Parkinson’s
Perhaps hereditary in less than 15 % of patients
Rare in monozygotic or dizygotic twins
Some “PARK” genes are associated with Parkinson’s, in some families
PARK1 – PARK 11
A parkin protein has been discovered, of unknown function
Familial cases tend to be younger than sporadic ones
Epidemiology of parkinson’s
Peak age of incidence 55 – 59 years, especially in the range of 40 – 70
The older the age of onset, in general, the more rapid the deterioration
Possible associations with Not smoking, Not consuming caffeine, somehow; but how can smoking and excessive use of caffeine prevent any disease?
More common in rural areas, perhaps from pesticides or other contaminants in well water?
A slight majority of Parkinson’s patients are men
Parkinson’s Best Treatment:
L-Dopa
Immunofluoresence studies in the 1950s and 1960s showed a deficiency of dopamine in the caudate and putamen, presumably due to loss of cellular input from the substantia nigra
Injection or oral intake of dopamine not helpful: dopamine DOES NOT cross the blood brain barrier
Levodopa DOES cross the BBB, and then it is converted to dopamine
Levodopa with carbidopa (a dopa-decarboxylase inhibitor) was introduced in the 1960s was very effective
Now sold as Sinemet, in ratios of 100mg/25mg, 100mg/10mg, and 250mg/25mg of levodopa/carbidopa
rate limiting step of dopamine and NE synthesis
tyrosine hydroxylase converting tyrosine to dopa